Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Moolec Science ( (MLEC) ) is now available.
Moolec Science SA announced the adjournment of its extraordinary general meeting of shareholders to December 16, 2025, due to the lack of a quorum, as only 39.846% of the shares were voted. The adjourned meeting will proceed with any number of shareholders present, allowing them to deliberate and resolve the matters intended for the original meeting, impacting the company’s governance and decision-making processes.
The most recent analyst rating on (MLEC) stock is a Sell with a $3.00 price target. To see the full list of analyst forecasts on Moolec Science stock, see the MLEC Stock Forecast page.
Spark’s Take on MLEC Stock
According to Spark, TipRanks’ AI Analyst, MLEC is a Underperform.
Moolec Science faces significant financial challenges with negative profitability and cash flow issues despite revenue growth. The technical analysis is bearish, and the valuation appears unfavorable with a negative P/E ratio. These factors contribute to a low overall stock score, highlighting the need for improved financial performance and market sentiment.
To see Spark’s full report on MLEC stock, click here.
More about Moolec Science
Moolec Science SA is a company based in the Cayman Islands, operating in the biotechnology industry. It focuses on developing innovative solutions in the field of molecular farming, which involves the production of animal proteins in plants, aiming to revolutionize the food and agriculture sectors.
Average Trading Volume: 162,313
Technical Sentiment Signal: Sell
Current Market Cap: $5.08M
Find detailed analytics on MLEC stock on TipRanks’ Stock Analysis page.